Earnings Expectation
Search documents
Mastercard's Q4 2025 Earnings: What to Expect
Yahoo Finance· 2025-12-31 14:53
Valued at a market cap of $518.5 billion, Mastercard Incorporated (MA) is a technology company that provides transaction processing and other payment-related products and services. The Purchase, New York-based company connects consumers, merchants, financial institutions, and governments by enabling secure and efficient digital transactions. It is scheduled to announce its fiscal Q4 earnings for 2025 in the near future. Ahead of this event, analysts expect this financial company to report a profit of $4. ...
GameStop Options Activity Builds as Traders Position for the Q3 Earnings Swing
Investing· 2025-11-28 13:46
Core Insights - GameStop shares are experiencing significant momentum ahead of the Q3 earnings report, with a premarket trading price of $22.50, reflecting a 3.97% increase [1][2] - The stock has risen 7.4% over the past week but is down approximately 31% year-to-date, as investors await clarity on retail performance and cash reserves deployment [2] - Analysts project earnings of $0.20 per share for Q3, a substantial increase from $0.06 in the same quarter last year, with revenue expectations at $987.3 million, representing a 15% year-over-year increase [4][5] Options Activity - There has been a notable increase in options trading, with around 78,000 contracts exchanged, predominantly call options, leading to a put/call ratio of 0.18, indicating strong bullish sentiment [3] - The options market anticipates significant movement post-earnings, with implied volatility rising to 60.78% and a 50% chance of the stock moving more than 9.24%, equating to approximately a $1.99 swing [6] Financial Position - GameStop holds a robust balance sheet with $8.7 billion in cash, more than double the $4.2 billion from the previous year, and has no long-term debt, providing exceptional liquidity [8] - The company also has Bitcoin holdings valued at $528.6 million, showcasing its unique position among traditional retailers [8] Valuation Metrics - The stock trades at a price-to-earnings ratio of 26.7, higher than the US Specialty Retail industry average of 18 and peers at 19.7, suggesting that investors are paying for future growth expectations [9] - Despite a 22.4% decline in three-year revenue growth, operating margins have improved to 3.77% from a historical median of negative 0.33%, indicating enhanced operational efficiency [10] Market Sentiment - Technical indicators show a 14-day RSI of 42.15, suggesting the stock is neither overbought nor oversold, while moving averages indicate a downward trend [11] - Insider activity has been cautious, with two insiders selling shares recently, and institutional ownership stands at 40.08% [11] - Investors are keenly awaiting the December 2 earnings call for insights on cash reserves deployment and operational stabilization strategies [12]
Top Wall Street Forecasters Revamp Agilent Expectations Ahead Of Q4 Earnings
Benzinga· 2025-11-24 13:30
Core Insights - Agilent Technologies, Inc. is set to release its fourth-quarter earnings results on November 24, with analysts expecting earnings of $1.58 per share, an increase from $1.46 per share in the same period last year [1] - The consensus estimate for Agilent's quarterly revenue is $1.83 billion, compared to $1.7 billion in the previous year [1] - A cash dividend of 25.5 cents per share was announced by Agilent on November 19 [1] Stock Performance - Agilent's shares increased by 4.3%, closing at $151.25 on Friday [2] Analyst Ratings - TD Cowen analyst Dan Brennan maintained a Buy rating and raised the price target from $150 to $162 [4] - UBS analyst Dan Leonard upgraded the stock from Neutral to Buy and increased the price target from $130 to $170 [4] - Rothschild & Co. analyst Natalya Davies initiated coverage with a Buy rating and a price target of $165 [4] - Wells Fargo analyst Brandon Couillard maintained an Overweight rating and raised the price target from $140 to $150 [4] - Baird analyst Catherine Schulte maintained an Outperform rating and increased the price target from $141 to $142 [4]
Top Wall Street Forecasters Revamp Barrick Mining Expectations Ahead Of Q3 Earnings - Barrick Mining (NYSE:B)
Benzinga· 2025-11-10 07:25
Barrick Mining Corporation (NYSE:B) will release earnings results for the third quarter before the opening bell on Monday, Nov. 10.Analysts expect the Toronto, Canada-based company to report quarterly earnings at 61 cents per share. That's up from 30 cents per share in the year-ago period. The consensus estimate for Barrick Mining's quarterly revenue is $4.36 billion, compared to $3.37 billion a year earlier, according to data from Benzinga Pro.On Friday, Barrick Mining announced that it has completed the d ...
Top Wall Street Forecasters Revamp Humana Expectations Ahead Of Q3 Earnings
Benzinga· 2025-11-05 07:59
Earnings Results - Humana Inc. is set to release its third-quarter earnings results on November 5, with expected earnings of $2.82 per share, a decrease from $4.16 per share in the same period last year [1] - The consensus estimate for Humana's quarterly revenue is $32.01 billion, up from $29.4 billion a year earlier [1] Dividend Announcement - On October 28, Humana declared a cash dividend of 88.5 cents per share to stockholders [2] - Following the announcement, Humana's shares rose by 0.7%, closing at $281.87 [2] Analyst Ratings and Price Targets - B of A Securities maintained a Neutral rating and raised the price target from $280 to $300 [4] - Mizuho maintained an Outperform rating and increased the price target from $300 to $345 [4] - Barclays maintained an Equal-Weight rating and cut the price target from $315 to $245 [4] - RBC Capital maintained an Outperform rating and raised the price target from $283 to $322 [4] - Argus Research reiterated a Hold rating with a price target of $281.99 [4]
Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q3 Earnings
Benzinga· 2025-10-24 08:14
Earnings Report - HCA Healthcare is set to release its third-quarter earnings results on October 24, with analysts expecting earnings of $5.73 per share, an increase from $4.90 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $18.56 billion, compared to $17.49 billion a year earlier [1] Recent Performance - On July 25, HCA Healthcare reported better-than-expected earnings for the second quarter [2] - Shares of HCA Healthcare fell by 0.2% to close at $440.16 on the last trading day [2] Analyst Ratings - Mizuho analyst Ann Hynes maintained an Outperform rating and raised the price target from $425 to $475 [4] - UBS analyst Andrew Mok maintained a Buy rating and increased the price target from $438 to $495 [4] - Goldman Sachs analyst Scott Fidel initiated a Buy rating with a price target of $470 [4] - Keybanc analyst Matthew Gilmore maintained an Overweight rating and raised the price target from $370 to $465 [4] - Barclays analyst Andrew Mok maintained an Overweight rating and increased the price target from $390 to $445 [4]
Broadridge Financial Solutions Earnings Preview: What to Expect
Yahoo Finance· 2025-10-21 08:54
Core Insights - Broadridge Financial Solutions, Inc. is set to announce its first-quarter results on November 4, with analysts expecting a non-GAAP profit of $1.19 per share, reflecting a 19% increase from the previous year [2] - The company has consistently met or exceeded analysts' earnings expectations for the past four quarters [2] - For fiscal 2026, Broadridge is projected to achieve an adjusted EPS of $9.32, a 9% increase from fiscal 2025, and further growth to $10.16 per share in fiscal 2027 [3] Financial Performance - Broadridge's stock has increased by 5.3% over the past 52 weeks, underperforming compared to the S&P 500 Index's 14.8% and the Technology Select Sector SPDR Fund's 24.8% gains [4] - Following the release of its Q4 results on August 5, the stock surged 6.8%, with revenues for the quarter rising 7.4% year-over-year to $1.4 billion, exceeding consensus estimates [5] - The adjusted EPS for Q4 increased by 1.4% year-over-year to $3.55, surpassing market expectations by 1.1% [5] Growth Outlook - Broadridge anticipates a 5% - 7% increase in recurring revenues on a constant currency basis for 2026, with adjusted EPS expected to rise by 8% - 12% [6] - The consensus rating for Broadridge is "Hold," with three analysts recommending "Moderate Buys" and six "Holds," indicating a cautious outlook [6] - The mean price target for the stock is $277.57, suggesting a potential upside of 20.3% from current levels [6]
Top Wall Street Forecasters Revamp W. R. Berkley Expectations Ahead Of Q3 Earnings
Benzinga· 2025-10-20 07:45
Core Viewpoint - W. R. Berkley Corporation is expected to report improved earnings and revenue for the third quarter compared to the previous year, indicating positive financial performance [1]. Earnings Expectations - The company is projected to report earnings of $1.10 per share for the third quarter, an increase from $0.93 per share in the same period last year [1]. - The consensus estimate for quarterly revenue is $3.15 billion, up from $2.93 billion a year earlier [1]. Recent Performance - In the second quarter, W. R. Berkley posted mixed results, with shares closing at $74.05, reflecting a 0.5% gain [2]. Analyst Ratings - UBS analyst Brian Meredith maintained a Buy rating and increased the price target from $80 to $87 [4]. - Wells Fargo analyst Elyse Greenspan maintained an Equal-Weight rating and raised the price target from $68 to $69 [4]. - Barclays analyst Alex Scott maintained an Underweight rating and boosted the price target from $62 to $66 [4]. - Keefe, Bruyette & Woods analyst Meyer Shields maintained a Market Perform rating and raised the price target from $65 to $75 [4]. - B of A Securities analyst Joshua Shanker downgraded the stock from Buy to Neutral while raising the price target from $73 to $74 [4].
Clorox’s Q1 2026 Earnings: What to Expect
Yahoo Finance· 2025-10-19 10:55
Company Overview - The Clorox Company (CLX) is a California-based consumer products firm known for its cleaning, household, and personal care brands, with a market cap of $14.6 billion and operations in over 100 countries employing about 8,000 people [1] Earnings Expectations - Clorox is expected to release its Q1 results on November 3, with analysts predicting an EPS of $0.78, a decline of 58.1% from $1.86 in the same quarter last year [2] - For fiscal 2026, EPS is projected to be $5.85, down 24.2% from $7.72 in fiscal 2025, but is expected to rise by 14.2% to $6.68 per share in fiscal 2027 [3] Stock Performance - CLX stock has decreased by 26.4% over the past 52 weeks, significantly underperforming the S&P 500 Index's 14.1% returns and the Consumer Staples Select Sector SPDR Fund's 2.8% increase during the same period [4] - Despite the stock's decline, Clorox announced a quarterly dividend of $1.24 on September 16, which led to a 1.7% increase in share price, highlighting its commitment to shareholder returns [5] Analyst Ratings - The consensus rating for CLX stock is "Hold," with 19 analysts providing ratings that include one "Strong Buy," 14 "Holds," and four "Strong Sell" ratings [6] - The mean price target for CLX is $128.44, indicating a potential upside of 7.3% from the current price level [6]
Top Wall Street Forecasters Revamp Bank of New York Mellon Expectations Ahead Of Q3 Earnings
Benzinga· 2025-10-15 10:46
Core Insights - The Bank of New York Mellon Corporation (NYSE:BK) is set to release its third-quarter earnings results on October 16, with analysts expecting earnings of $1.77 per share, an increase from $1.52 per share in the same period last year [1] - The projected quarterly revenue for BNY Mellon is $4.98 billion, up from $4.65 billion a year earlier [1] Financial Activities - On September 3, BNY Mellon announced a public offering of $500 million in depositary shares representing interests in preferred stock [2] - The stock price of Bank of New York Mellon increased by 0.8%, closing at $107.11 on a recent Tuesday [2] Analyst Ratings - Goldman Sachs analyst Alexander Blostein maintained a Buy rating and raised the price target from $106 to $120 [4] - BMO Capital analyst Brennan Hawken initiated coverage with an Outperform rating and a price target of $125 [4] - Truist Securities analyst David Smith maintained a Hold rating and increased the price target from $109 to $118 [4] - Evercore ISI Group analyst Glenn Schorr maintained an In-Line rating and raised the price target from $91 to $110 [4] - Citigroup analyst Keith Horowitz maintained a Neutral rating and increased the price target from $92 to $105 [4]